Cargando…
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
BACKGROUND: As the COVID-19 pandemic continues to spread, the number of associated deaths continues to increase, especially among those with pre-existing conditions. Azvudine is recommended as a priority treatment for patients with COVID-19, but its efficacy in patients with pre-existing conditions...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167478/ https://www.ncbi.nlm.nih.gov/pubmed/37193346 http://dx.doi.org/10.1016/j.eclinm.2023.101981 |